CI — Cell Impact AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK26.90m
- SEK40.39m
- SEK5.57m
Annual cashflow statement for Cell Impact AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2022 October 22nd | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | -29.1 | -103 | -119 | -99 | -128 |
| Depreciation | |||||
| Non-Cash Items | 4.9 | 16.4 | 5.06 | 19.5 | 49.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.82 | -18.9 | -11.6 | -9.04 | 2.87 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -34 | -106 | -106 | -62.2 | -45.4 |
| Capital Expenditures | -0.722 | -68.4 | -53.5 | -14.4 | -1.93 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.004 | 0 | -0.001 | 4.23 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -10.1 | -68.4 | -53.5 | -14.4 | 2.3 |
| Financing Cash Flow Items | 0 | -45.3 | -21.9 | -8.18 | -5.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 310 | 94.6 | -2.84 | 33.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | 136 | -64.8 | -79.5 | -9.53 |